Patents Assigned to EDISBIOTECH CO., LTD.
  • Patent number: 12227592
    Abstract: The present invention relates to a monoclonal antibody which specifically binds to an EGF2 domain of colon cancer secreted protein-2 (CCSP-2), or an antigen-binding fragment thereof. The monoclonal antibody or the antigen-binding fragment thereof of the present invention specifically binds to the EGF2 domain of CCSP-2, and thus has significantly increased affinity compared with existing peptides specifically binding to CCSP-2 and further increased specificity compared with existing antibodies to CCSP-2. Therefore, in future, accurate diagnosis can be achieved by specific detection of CCSP-2 in the protein level.
    Type: Grant
    Filed: January 29, 2020
    Date of Patent: February 18, 2025
    Assignees: THE ASAN FOUNDATION, EDISBIOTECH CO., LTD., UNIVERSITY OF ULSAN FOUNDATION FOR INDUSTRY COOPERATION
    Inventors: Seung-Jae Myung, Eun-Ju Do, Jayoung Kang, Hye-Nam Son, Hyori Kim, A-Neum Lee, Yeong Hui Cho
  • Publication number: 20220089774
    Abstract: The present invention relates to a monoclonal antibody which specifically binds to an EGF2 domain of colon cancer secreted protein-2 (CCSP-2), or an antigen-binding fragment thereof. The monoclonal antibody or the antigen-binding fragment thereof of the present invention specifically binds to the EGF2 domain of CCSP-2, and thus has significantly increased affinity compared with existing peptides specifically binding to CCSP-2 and further increased specificity compared with existing antibodies to CCSP-2. Therefore, in future, accurate diagnosis can be achieved by specific detection of CCSP-2 in the protein level.
    Type: Application
    Filed: January 29, 2020
    Publication date: March 24, 2022
    Applicants: THE ASAN FOUNDATION, EDISBIOTECH CO., LTD., UNIVERSITY OF ULSAN FOUNDATION FOR INDUSTRY COOPERATION
    Inventors: Seung-Jae MYUNG, Eun-Ju DO, Jayoung KANG, Hye-Nam SON, Hyori KIM, A-Neum LEE, Yeong Hui CHO